SMTL ID : 6s4j.1

Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

hetero-3-3-mer

Ligands

3 x IMD: IMIDAZOLE(Non-covalent)

IMD.1: 9 residues within 4Å: Chain A: L.13, L.16 Chain B: F.1, V.2, Q.4, L.6, A.14, L.17, V.18 2 PLIP interactions: 2 interactions with chain B Water bridges: B:F.1, B:Q.4 IMD.3: 9 residues within 4Å: Chain C: L.13, L.16 Chain D: F.1, V.2, Q.4, L.6, A.14, L.17, V.18 2 PLIP interactions: 2 interactions with chain D Water bridges: D:F.1, D:Q.4 IMD.5: 9 residues within 4Å: Chain E: L.13, L.16 Chain F: F.1, V.2, Q.4, L.6, A.14, L.17, V.18 2 PLIP interactions: 2 interactions with chain F Water bridges: F:F.1, F:Q.4

3 x KUT: KUT [2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl](Covalent)

KUT.2: 18 residues within 4Å: Chain A: N.21 Chain B: V.12, Y.16, F.24, H.25, Y.26, K.28 Chain E: V.3 Chain F: C.7, G.8, S.9, V.12, E.13, Y.16, Y.26, P.27 Ligands: KUT.4, KUT.6 12 PLIP interactions: 8 interactions with chain F, 4 interactions with chain B Hydrophobic interactions: F:V.12, F:E.13, F:Y.16, F:Y.16, B:V.12, B:F.24 Hydrogen bonds: F:G.8, F:Y.26, F:Y.26, F:Y.26, B:Y.26, B:K.28 KUT.4: 18 residues within 4Å: Chain A: V.3 Chain B: C.7, G.8, S.9, V.12, E.13, Y.16, Y.26, P.27 Chain C: N.21 Chain D: V.12, Y.16, F.24, H.25, Y.26, K.28 Ligands: KUT.2, KUT.6 12 PLIP interactions: 8 interactions with chain B, 4 interactions with chain D Hydrophobic interactions: B:V.12, B:E.13, B:Y.16, B:Y.16, D:V.12, D:F.24 Hydrogen bonds: B:G.8, B:Y.26, B:Y.26, B:Y.26, D:Y.26, D:K.28 KUT.6: 18 residues within 4Å: Chain C: V.3 Chain D: C.7, G.8, S.9, V.12, E.13, Y.16, Y.26, P.27 Chain E: N.21 Chain F: V.12, Y.16, F.24, H.25, Y.26, K.28 Ligands: KUT.2, KUT.4 12 PLIP interactions: 8 interactions with chain D, 4 interactions with chain F Hydrophobic interactions: D:V.12, D:E.13, D:Y.16, D:Y.16, F:V.12, F:F.24 Hydrogen bonds: D:G.8, D:Y.26, D:Y.26, D:Y.26, F:Y.26, F:K.28

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hubalek, F. et al., Molecular engineering of safe and efficacious oral basal insulin. Nat Commun (2020)

Release Date

2020-07-15

Peptides

Insulin: ACE
Insulin: BDF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
A

E
A

B
B

D
B

F
B

Insulin

Insulin

Related Entries With Identical Sequence